drugset / Trial / NCT02248883
Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
To demonstrate that tipranavir (TPV) co-administered with ritonavir (RTV) does not affect the QT interval more than placebo co-administered with ritonavir
Timeline
- Start
- 2005-12
- Primary completion
- 2006-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | — | — |
| Subject | Tipranavir | Small molecule | — | — |
| Background | Ritonavir | Other / unclassified | — | — |
Indications
No indication recorded.